Fluidigm Selected for $37 Million Project under National Institutes of Health RADx Initiative
Fluidigm Corporation, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, for a proposed project under the agency’s Rapid Acceleration of Diagnostics (RADx) program. The project, with a total … Continue reading Fluidigm Selected for $37 Million Project under National Institutes of Health RADx Initiative Continue Reading


WisdomTree Investments, Inc. reported financial results for the second quarter of 2020. During the second quarter of 2020, we experienced a partial recovery of our AUM which was adversely impacted by severe market declines arising from the COVID-19 pandemic toward the end of the prior quarter. This recovery was driven principally by market appreciation, resulting …